University of Galway

Insight at the University of Galway Pioneers the Future of Aortic Care with Rackspace Technology Cloud-Based Diagnostics on AWS

Retrieved on: 
Tuesday, October 3, 2023
Cloud, Partnership, University, Education, University of Galway, Research, Rackspace Technology, Organization, SAN, European Open Science Cloud, Diagnosis, AI, Insight, NREN, Rest, AWS, Medical device

The groundbreaking project is backed by Open Clouds for Research Environments (OCRE) funding.

Key Points: 
  • The groundbreaking project is backed by Open Clouds for Research Environments (OCRE) funding.
  • “Since January 2021, Rackspace has been a leading contributor in the European Open Science Cloud marketplace.
  • “Rackspace Technology has exceptional managed services expertise within the AWS cloud environment and has delivered truly valuable business outcomes for customers across EMEA.
  • Click here to read the Rackspace Technology University of Galloway case study, and to watch the case study video, click here .

Online abuse could drive women out of political life – the time to act is now

Retrieved on: 
Tuesday, September 26, 2023
Rape, Verbal abuse, University, Democracy, Violence, European Parliament, Life, Socialist Party of Ukraine, Politics, European, Cyberbullying, Solution, Perception, Woman, Intelligence, University of Galway, Research, Goal, Government, Union, Economist Intelligence Unit, Bullying, Abuse, Indifference, Retirement, Man, Collection, National Democratic Institute, Risk, Algorithm, Intimidation, Assault, Health, Death, Safety, Social media, Female, Birth control, Nursing, Ridesharing, Drug, Jacinda Ardern

It is becoming increasingly evident that life in modern politics is presenting women with a stark choice – endure almost constant online threats and abuse or get out of public life.

Key Points: 
  • It is becoming increasingly evident that life in modern politics is presenting women with a stark choice – endure almost constant online threats and abuse or get out of public life.
  • But the social media era has normalised ever more aggressive forms of abuse.
  • The abuse against Ardern has been so intense that even in retirement she’s expected to have extra police protection.
  • The Economist Intelligence Unit has reported that more than one in three women have experienced online violence.

Driving women out

    • A global survey by Washington-based non-profit National Democratic Institute found that more than half of young women who posted political opinions online were attacked for their views.
    • This amounts to compelling evidence that the problem runs deep, illustrating that people attempting to undermine a government have recognised attacking women as a winning strategy.
    • The examples highlighted in the report don’t merely revolve around hatred towards these women.
    • After years of progress on increasing female participation in political life, democracies around the world are now in real danger of regressing if women are driven out of politics.

We know the problem, we know the solutions

    • Laws already exist that are supposed to protect women from this kind of abuse but they are not being vigorously enforced.
    • It’s also time to rein in the tech platforms and hold them legally accountable for the toxic content they host, pushed out by their algorithms.
    • And if the issue isn’t addressed, it could lead to dire consequences for democracy as women retreat from positions of power.

FIS Announces Appointment of James Kehoe as Chief Financial Officer

Retrieved on: 
Tuesday, August 22, 2023
Software, Payments, Finance, Banking, Professional Services, Technology, Fintech, Digital Cash Management, Digital Assets, Takeda Pharmaceutical Company, Walgreens Boots Alliance, Hoag, Kehoe, Kraft Foods, FIS, University College Dublin, University of Galway, EBITDA, Business studies, Gildan, CFO, Growth, NYSE, Management

FIS ® (NYSE: FIS), a global leader in financial services technology, today announced the appointment of James Kehoe as Chief Financial Officer (CFO), effective August 21, 2023.

Key Points: 
  • FIS ® (NYSE: FIS), a global leader in financial services technology, today announced the appointment of James Kehoe as Chief Financial Officer (CFO), effective August 21, 2023.
  • “We are pleased to welcome James Kehoe to the FIS team.
  • He is an accomplished and internationally experienced CFO with a distinguished record of success in driving shareholder value,” said FIS Chief Executive Officer and President Stephanie Ferris.
  • He joins FIS from Walgreens Boots Alliance, where he served as Executive Vice President and Global Chief Financial Officer since 2018.

Factor Bioscience Announces Publication of Preclinical Results of Aerosolized mRNA For the Treatment of Pneumonia

Retrieved on: 
Tuesday, February 28, 2023
Infection, Death, Therapy, Protein, Principal, University, Mortality, Research, Cell, Pulmonary edema, Research fellow, University of Galway, Senior lecturer, Inflammation, IPS, Medical device, Messenger, Lung, Vaccine, Pneumonia

CAMBRIDGE, Mass., Feb. 28, 2023 /PRNewswire/ -- Factor Bioscience Inc. ("Factor"), a Cambridge-based biotechnology company focused on developing mRNA and cell-engineering technologies, announced the results of preclinical testing of aerosolized mRNA formulations currently under development for the treatment of pneumonia-associated lung inflammation. The study was led by Factor's collaborator, Dr. Daniel O'Toole, Senior Research Fellow, Senior Lecturer in Lung Regenerative Medicine and Principal Investigator in the CÚRAM and REMEDI institutes at the University of Galway.

Key Points: 
  • CAMBRIDGE, Mass., Feb. 28, 2023 /PRNewswire/ -- Factor Bioscience Inc. ("Factor"), a Cambridge-based biotechnology company focused on developing mRNA and cell-engineering technologies, announced the results of preclinical testing of aerosolized mRNA formulations currently under development for the treatment of pneumonia-associated lung inflammation.
  • The ability to directly express anti-inflammatory proteins in lung tissue makes aerosolized mRNA an attractive candidate therapy for pneumonia.
  • "We are incredibly proud of our collaboration with CÚRAM, and are excited about the results of this study," said Dr. Christopher Rohde, Chief Technology Officer of Factor.
  • The results of this study were published last week in Nucleic Acid Therapeutics: https://doi.org/10.1089/nat.2022.0049

WHYZE Health and Blackrock Health Galway Clinic Announce Pilot Study of WHYZE Health Platform

Retrieved on: 
Wednesday, February 15, 2023
Data Management, Biotechnology, Practice Management, Technology, Managed Care, Health, Pharmaceutical, Oncology, Research, Software, Science, CMO, Physician, Prostate cancer, Galway Clinic, BBC, Aircraft, Patient, Interim, University, Risk, University of Galway, NUIG, Multimedia, Communication, RWE, Nursing, Medical imaging

In January 2023, WHYZE Health Ltd. and Blackrock Health Galway Clinic began a pilot study of WHYZE Health’s platform.

Key Points: 
  • In January 2023, WHYZE Health Ltd. and Blackrock Health Galway Clinic began a pilot study of WHYZE Health’s platform.
  • “WHYZE and Blackrock Health Galway Clinic are working together to demonstrate the real-world evidence (RWE) power of patient-reported outcomes … to improve health outcomes and quality of care,” said WHYZE Health CEO Frances Abeton.
  • View the full release here: https://www.businesswire.com/news/home/20230215005267/en/
    From left to right: Prof. Frank Sullivan, CMO WHYZE Health and Director Radiation Oncology, Prostate Cancer Institute (NUIG) Blackrock Health, Galway Clinic; Phil Blackwell, Chief Technology Officer, WHYZE Health; Dr. Tanya Mulcahy, Director, Health Innovation Hub Ireland; Frances Abeton CEO, WHYZE Health; Evelyn Smyth, Interim CEO, Galway Clinic; Abby Langtry, Chief Patient Officer, WHYZE Health; Alyson Banks, Patient Safety Executive, Galway Clinic
    Through RWE, the WHYZE Health Platform aids the delivery of informed prostate cancer treatment plans.
  • The WHYZE Health pilot study is part of the Health Innovation Hub Ireland Open Call 2022 .

Innovative start-up company Neuronic debuts home-use brain-enhancing infrareddevice, surpassing $1.2 million in sales

Retrieved on: 
Thursday, February 2, 2023
Light-emitting diode, PBM, Santa Clara University, Patient, Cell, Inflammation, University, Trustpilot, Neuro, FDA, University of Galway, Research, Multimedia, Cholinergic neuron, Medical device, Dementia, Alzheimer's disease, Mobile phone, EU

GALWAY, Ireland, Feb. 2, 2023 /PRNewswire/ -- In its first year on the market, Neuronic has helped over 350 customers across 23 countries. Neuronic is a digital phototherapeutics technology company based in Europe and rapidly expanding in the US. The company is affiliated with Apollo Health and Quietmind Foundation, in their shared mission of optimizing brain health and wellness. Research has shown that near-infrared light reduces symptoms in Alzheimer's dementia patients and those suffering from other neurodegenerative conditions.

Key Points: 
  • GALWAY, Ireland, Feb. 2, 2023 /PRNewswire/ -- In its first year on the market, Neuronic has helped over 350 customers across 23 countries.
  • Neuronic is a digital phototherapeutics technology company based in Europe and rapidly expanding in the US.
  • The company is affiliated with Apollo Health and Quietmind Foundation , in their shared mission of optimizing brain health and wellness.
  • Research has shown that near-infrared light reduces symptoms in Alzheimer's dementia patients and those suffering from other neurodegenerative conditions.